Clinical Trial Update: FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for FM101 in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• FM101

Snippet

Sponsor: Future Medicine | Conditions: Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Phase 2 | Status: UNKNOWN